Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
 
Register | Sign in
Home Page>Products
  Product News
City Launches New Long-life O2 and Emissions Sensors at MICONEX
Saturday, September 06, 2014
MICONEX show in Beijing, China from 23-26 September.

Eagle Genomics Launches Eaglecore™
Saturday, September 06, 2014
New software platform will improve bioinformatics research.

Veeco Launches EPIK700 MOCVD System
Saturday, September 06, 2014
Platform combines best-in-class yields and highest productivity to lower LED manufacturing costs.

Precise and Easy Static Headspace Analysis of Residual Solvents
Friday, September 05, 2014
Analysis of residual solvents in flexible packaging using a headspace autosampler.

Introduction to a Novel Chromatin Immunoprecipitation (ChIP) Method
Friday, September 05, 2014
An informative 8-page brochure from Porvair introduces Chromatrap® ChIP assay technology.

Linguamatics I2E Semantic Enrichment Named as a KMWorld 2014 Trend-setting Product
Friday, September 05, 2014
Brings powerful semantic and natural language processing (NLP) technology.

Custom Specified Laboratory Apparatus
Friday, September 05, 2014
Company’s custom services draw upon expertise in areas including high pressure reactors, heating / cooling block technology.

BIOCRATES Launches First-ever Standardized Metabolomics-based Bile Acids Kit
Friday, September 05, 2014
BIOCRATES Life Sciences has further expanded its range of metabolomics-based kits with the addition of its assay for the determination of endogenous bile acids, allowing a panel of up to 19 analytes to be simultaneously quantitated from a single 10 µL sample of human or mouse plasma.

EpiCypher™ Announces Next-Generation Histone Peptide Array
Friday, September 05, 2014
EpiTitan™ to replace first-generation EpiGold™ array.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 10502
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv